The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...

Hopes for millions of people with Alzheimer's could be on the horizon after a new drug that slows down the progression of the ...

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

The Alzheimer's epidemic continues to cast a shadow over the lives of millions of people. With no effective treatment ...

Spread the loveA new Alzheimer’s treatment has shown unprecedented success in late-stage clinical trials, offering hope to ...

In a year plagued by the challenges of Alzheimer's disease, 2024 brought a glimmer of hope with the approval of the third new ...

China is the fourth major market where Kisunla has been approved after the US, Japan, and GB. It gets the green light there ...

Anavex Life Sciences' ANAVEX 2-73 shows promise in treating Alzheimer's, with strong efficacy in slowing cognitive and ...

Dec. 19, 2024 — Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, ... Study Supports New Blood ...

A new compound, called VU319, has delivered promising results in a Phase 1 trial for treating Alzheimer's disease and other neudegenerative conditions. | Drug Discovery And Development ...

According to Phipps, the drugs currently available to treat Alzheimer’s have only eased the symptoms rather than stop its ...

Immune cells in the brain called microglia can partially break down large amyloid plaques characteristic of Alzheimer's disease by latching on to them, forming a sort of external stomach and releasing ...